The Efficacy in Treatment of Female Pattern Hair Loss Using 5% Minoxidil Solution Combinded With Zinc Supplement
Information source: Siriraj Hospital
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Female Pattern Alopecia
Intervention: 15 mg Chelate zinc supplement (Drug); Placebo drug supplement (Drug)
Phase: Phase 1/Phase 2
Status: Recruiting
Sponsored by: Siriraj Hospital Overall contact: Rattapon Thuangtong, MD, Phone: +662 419-7000, Ext: 4333, Email: rattapongthuangtong@yahoo.com
Summary
Zinc supplement is a popular trace element gave to Female pattern hair loss (FPHL) patient.
But the type of patient, efficacy, and side effect in detail of zinc supplement are not well
characterized. The purpose of this study is to determine efficacy and side effect of
chelated zinc in FPHL who using 5%minoxidil solution.
Clinical Details
Official title: A Pilot Study of the Efficacy in Treatment of Female Pattern Hair Loss Using 5% Minoxidil Solution Combinded With Oral Chelated Zinc Supplement
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
Primary outcome: Compare clinical improvement before and after treatmentCompare hair density before and after treatmen Compare average hair shaft diameter before and after treatment
Secondary outcome: Number of pateint with Side effect
Detailed description:
5%minoxidil solution is standard treatment for Female pattern hair loss (FPHL) patient. We
gave 15mg chelate Zinc / Placebo drug to patient as an additional trace element. Then
measure growth of hair by Global photograph, Microscope hair count, micrometer and record
case and side effect during 10 months of treatment.
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- Female Pattern Hair Loss ( Ludwig classification grade 1 and 2 )
Exclusion Criteria:
- Underlying disease ; Anemia, Diabetes, chronic alcoholism, previous gastrointestinal
surgery, short bowel syndrome, Crohn's disease, digestive disorder,
hypo/hyperthyroidism, sickle cell disease, autoimmune disease, iron deficiency
- Psychologic disorder trichotillomania
- Diet control
- Pregnancy or lactation
- On supplement diet within 3 month prior to trial
Locations and Contacts
Rattapon Thuangtong, MD, Phone: +662 419-7000, Ext: 4333, Email: rattapongthuangtong@yahoo.com
Siriraj Hospital, Bangkok 10700, Thailand; Recruiting Rattapon Thuangtong, MD, Phone: +662 419-7000, Ext: 4333, Email: rattapongthuangtong@yahoo.com
Additional Information
Starting date: January 2012
Last updated: August 7, 2012
|